ROR1 and B-cell chronic lymphocytic leukemia: ROR1 was described to increase on CLL cells upon disease progression [72], and patients with high ROR1 expression had significantly shorter therapy-free survival (TFS) as well as overall survival (OS), indicating that ROR1 is associated with a more aggressive disease [36].